clinical trial · NCT03729349
Golimumab for Adherence in Rheumatoid Arthritis
Arthritis, RheumatoidGolimumab
brief summary
The purpose of this study is to determine if non-adherence to Rheumatoid Arthritis (RA) drugs in participants treated with biologic disease modifying anti-rheumatic drugs (DMARDs) is associated with a greater incidence of disease in clinical practice.
started
Jan 15, 2019
primary completion
Jun 19, 2023
completion
Jun 19, 2023
last updated
Jul 18, 2024
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol